Results: 1-7 |
Results: 7

Authors: Gutheil, J
Citation: J. Gutheil, Monoclonal antibodies and cancer, CR R ONC H, 40(1), 2001, pp. 1-2

Authors: Gutheil, J
Citation: J. Gutheil, The promise of monoclonal antibodies for the therapy of cancer, CR R ONC H, 38(1), 2001, pp. 1-2

Authors: Batist, G Ramakrishnan, G Rao, CS Chandrasekharan, A Gutheil, J Guthrie, T Shah, P Khojasteh, A Nair, MK Hoelzer, K Tkaczuk, K Park, YC Lee, LW
Citation: G. Batist et al., Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer, J CL ONCOL, 19(5), 2001, pp. 1444-1454

Authors: Saleh, MN Gutheil, J Moore, M Bunch, PW Butler, J Kunkel, L Grillo-Lopez, AJ LoBuglio, AF
Citation: Mn. Saleh et al., A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia, SEMIN ONCOL, 27(6), 2000, pp. 99-103

Authors: Gutheil, J Finucane, D
Citation: J. Gutheil et D. Finucane, Thalidomide therapy in refractory solid tumour patients, BR J HAEM, 110(3), 2000, pp. 754-754

Authors: Wiseman, GA White, CA Witzig, TE Gordon, LI Emmanouilides, C Raubitschek, A Janakiraman, N Gutheil, J Schilder, RJ Spies, S Silverman, DHS Grillo-Lopez, AJ
Citation: Ga. Wiseman et al., Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody, CLIN CANC R, 5(10), 1999, pp. 3281S-3286S

Authors: Witzig, TE White, CA Wiseman, GA Gordon, LI Emmanouilides, C Raubitschek, A Janakiraman, N Gutheil, J Schilder, RJ Spies, S Silverman, DHS Parker, E Grillo-Lopez, AJ
Citation: Te. Witzig et al., Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsedor refractory CD20(+) B-cell non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3793-3803
Risultati: 1-7 |